The National Institutes of Health (NIH) has allowed a contract for the dissemination of embryonic stem cell lines approved for US government funding to lapse, shuttering a key stem cell bank, and doubling the price researchers pay for samples of some human embryonic stem cell (hESC) lines.
Researchers hoped that stem cell research would be moving forward by leaps and bounds with the number of hESC lines approved for federal funding more than doubling since the limitations of the Bush administration were lifted in 2009. But a major stumbling block remains -- getting those newly approved lines to the researchers who want to use them. In 2005, the linkurl:National Stem Cell Bank;http://www.wicell.org/index.php?option=com_content&task=category§ionid=7&id=303&Itemid=252 (NSCB) was established at the linkurl:WiCell Institute;http://www.wicell.org/ in Wisconsin to distribute the 21 Bush administration-sanctioned lines to labs around the country. But last month, the NIH let the NSCB...
Image: Wikimedia commons,
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?